Farxiga is meant to be used with a combination of diet and exercise in order to improve glycemic control and lower blood sugar in adults with type 2 diabetes mellitus. These inhibitors lower a person’s blood sugar by causing the kidneys to remove it through the urine.
Bristol-Myers Squibb and AstraZeneca is a partnership medical device company that manufactures the drug Farxiga — a controversial drug that has recently been linked to kidney failure, heart attacks, and ketoacidosis.
The failure to warn patients of the possible risks the type 2 diabetes drug is capable of creating may lead to many lawsuits. Plaintiffs may claim that if manufacturers and marketers had properly warned of the risks, patients would have been prescribed and taken a substitute medication for their diabetes, and would have had their health monitored on a more routine basis for potential signs of heart issues, renal impairment, and high level of ketones.
Why is Farxiga Dangerous?
Type 2 diabetes affects nearly 20 million Americans, a condition where a person’s body does not respond well to sugar or store it properly. Diabetes can cause any serious health problems including kidney disease and various cancers. Unfortunately, although FDA approved, is more prone to cause these diseases than existing drugs.
The FDA rejected the drug two years before the drug was released (2014) due to cancer concerns and questions about how well the drug prevents its risk of diabetes. Farxiga does not usually cause low blood sugar, unless prescribed with other anti-diabetic medications. The FDA issued a warning in May 2015, regarding the use of the new medications including Farxiga and Xigduo XR. This announcement warns of the possibility of the development of diabetic ketoacidosis and kidney failure while using SGLT2 inhibitors.
FDA Issues Recommendations About Dangers of Farxiga
The U.S. Food and Drug Administration (FDA) has strengthened the existing warning about the risk of the acute kidney injury for the type 2 diabetes medicine. Health care professionals are advised to consider factors that may predispose patients to acute kidney injury prior to starting the medication. However, if the medicine is prescribed and acute kidney injury occurs, it is recommended to promptly discontinue the drug and treat the kidney impairment.
From March 2013 to October 2016, the FDA received reports of 101 confirmable cases of acute kidney injury.
Can I File A Farxiga Lawsuit?
Our lawyers can help if you or someone you care about contracted a severe — or possibly fatal — infection as a result of being exposed to severe side effects this drug causes.
Our top Farxiga case lawyers are handling individual litigation nationwide and currently accepting new cases in all 50 states.
Both patients and their families are seeking compensation for injuries. You may be entitled to a settlement if you were harmed by Farxiga
Our No-Fee Promise On Farxiga Cases
You can afford to have our great team of Farxiga lawyers on your side. If you choose us, it literally costs you nothing to get started. We promise you in writing:
- No money to get started
- We pay all case costs and expenses
- No legal fees whatsoever unless you receive a Farxiga settlement
- Phone calls are always free
How Do I Start A Farxiga Claim?
Our Farxiga case lawyers will help you file your lawsuit. To get started, you can:
- Submit the Free Case Review Box on this page, or
- Call (866) 280-3417 any time of day to tell us about your case.
We will listen to your story and answer your questions. If you have a claim, we will start immediately.
WARNING: There are strict time deadlines for filing Farxiga claims.